Introduction
The Treponema pallidum haemagglutination assay (TPHA) is at present the most specific method for the detection of antibodies against T pallidum.' There is no difference between the results of the TPHA and the automated microhaemagglutination assay using Tpallidum as antigen (AMHA-TP)2; the latter is much more economical and suitable for mass screening.
The sensitivity of the test in early infections depends on the IgM-binding capacity of the reagents, which may vary between different kits from the same manufacturer. The IgG reactivity is usually very sensitive and therefore the AMHA-TP test is used for screening in routine serology for syphilis.
The determination of the margin of error of the haemagglutination method is consequently of major importance. A previous study3 found that 2262 (0 45%) of 503 848 samples were reactive in the AMHA-TP but non-reactive in the fluorescent T pallidum antibody-absorption (FTA-ABS) and in Reactivity in the AMHA-TP and the FTA-ABS tests indicates a former infection with T pallidum. However, less than one-third (31 * 28%) of the patients studied were reported to have had a history of syphilis. It can hardly be assumed that 68-72% of the donors had never known of a previous infection or had never noticed any symptoms of syphilis before their present examination. This seems to indicate that the record of a history of syphilis on the request forms accounts for only a small percentage of patients with a previous infection.
The evaluation of 371 patients with an isolated reactivity in the AMHA-TP test showed that 320 (86 25%) had a history or serological evidence of a previous syphilitic infection. Only 26 (7 01 %) could not remember or denied having a history of syphilis. The reliability of these statements has been discussed above. Twenty-five (6 74%) gave non-reactive AMHA-TP test results at least once on later occasions. Several of these patients might have had a treponemal infection long ago and were just on the verge of permanent reversal of the AMHA-TP reactivity. False reactivity in the AMHA-TP test can therefore not be excluded in about 13 75Vo of the sera showing an isolated reactivity in this test. The actual figure is most probably much smaller but this cannot yet be proved.
The number of samples which were reactive in the AMHA-TP and the VDRL tests but non-reactive in the FTA-ABS test is very small (57). The percentage of donors with a history of syphilis (36 840o) is very similar to that of donors with serological evidence of a former syphilitic infection (31 * 28%). Further investigations on this point will be carried out.
Four hundred and sixty-two sera showed an isolated reactivity in the VDRL test; 31 (6 71 7o) of these patients gave a history of syphilis but could not be traced for further investigation. Most of these results in this group were probably biological falsepositive results. Nevertheless, the sera of patients with an isolated VDRL reactivity and a history of syphilis need further consideration.
Special interest was focussed on the group of 34 sera which were non-reactive in the AMHA-TP but reactive in the FTA-ABS and VDRL tests, of which 26 could be reinvestigated. The non-reactive AMHA-TP results of eight patients with primary syphilis were due to the regrettable fact that the TPHA reagents became less sensitive for the detection of early infection. The manufacturers (Fujizoki) 
